184 related articles for article (PubMed ID: 33590711)
1. Change of right ventricular systolic pressure can indicate dasatinib-induced pulmonary arterial hypertension in chronic myeloid leukemia.
Lee SE; Hyun Kong J; Kim SH; Jang EJ; Chung NG; Cho B; Joong Oh S; Jung HE; Youn HJ; Chung WB; Kim DW
Cancer Med; 2021 Mar; 10(5):1515-1524. PubMed ID: 33590711
[TBL] [Abstract][Full Text] [Related]
2. Reversible Pulmonary Arterial Hypertension Associated with Dasatinib for Chronic Myeloid Leukemia.
Hong JH; Lee SE; Choi SY; Kim SH; Jang EJ; Bang JH; Park JE; Jeon HR; Oh YJ; Yi JE; Jung HO; Youn HJ; Kim DW
Cancer Res Treat; 2015 Oct; 47(4):937-42. PubMed ID: 25648097
[TBL] [Abstract][Full Text] [Related]
3. [Chronic myeloid leukemia complicated by pulmonary hypertension during dasatinib therapy: a single-center retrospective study].
Edahiro Y; Takaku T; Konishi H; Tsukune Y; Fujioka I; Takasu K; Gotoh A; Daida H; Komatsu N
Rinsho Ketsueki; 2017; 58(11):2213-2218. PubMed ID: 29212971
[TBL] [Abstract][Full Text] [Related]
4. [Reversible dasatinib-related pulmonary arterial hypertension in a CML patient].
Nagasaki J; Aoyama Y; Nomoto Y; Ido K; Ichihara H; Mugitani A
Rinsho Ketsueki; 2016 May; 57(5):618-23. PubMed ID: 27263788
[TBL] [Abstract][Full Text] [Related]
5. [Repeated partially reversible pulmonary arterial hypertension related to dasatinib: a case report and literature review].
Jin J; Xu XM; Wang C
Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb; 39(2):83-7. PubMed ID: 26879609
[TBL] [Abstract][Full Text] [Related]
6. Dasatinib-Induced Pulmonary Arterial Hypertension.
Orlikow E; Weatherald J; Hirani N
Can J Cardiol; 2019 Nov; 35(11):1604.e1-1604.e3. PubMed ID: 31590985
[TBL] [Abstract][Full Text] [Related]
7. Computed tomography-measured pulmonary artery to aorta ratio and EUTOS score for detecting dasatinib-induced pulmonary arterial hypertension.
Toya T; Nagatomo Y; Kagami K; Yukino M; Yasuda R; Namba T; Ido Y; Kobayashi S; Masaki N; Yada H; Kimura F; Adachi T
Int J Cardiovasc Imaging; 2019 Aug; 35(8):1435-1442. PubMed ID: 30715668
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib-induced pulmonary arterial hypertension - A rare late complication.
Ibrahim U; Saqib A; Dhar V; Odaimi M
J Oncol Pharm Pract; 2019 Apr; 25(3):727-730. PubMed ID: 29343154
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary arterial hypertension caused by treatment with dasatinib for chronic myeloid leukemia -critical alert-.
Sano M; Saotome M; Urushida T; Katoh H; Satoh H; Ohnishi K; Hayashi H
Intern Med; 2012; 51(17):2337-40. PubMed ID: 22975544
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of pulmonary arterial hypertension in patients receiving dasatinib.
Shah NP; Wallis N; Farber HW; Mauro MJ; Wolf RA; Mattei D; Guha M; Rea D; Peacock A
Am J Hematol; 2015 Nov; 90(11):1060-4. PubMed ID: 26284693
[TBL] [Abstract][Full Text] [Related]
11. [Dasatinib-related pulmonary adverse events in patients with chronic myeloid leukemia].
Yang S; Qin YZ; Lai YY; Shi HX; Hou Y; Huang XJ; Jiang Q
Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1013-1019. PubMed ID: 33445849
[No Abstract] [Full Text] [Related]
12. [Development of pulmonary arterial hypertension during oral dasatinib therapy for chronic myelogenous leukemia].
Morishita S; Hagihara M; Itabashi M; Ishii Y; Yamamoto W; Numata A; Motohashi K; Matsumoto K; Fujisawa S; Nakajima H
Rinsho Ketsueki; 2016 Aug; 57(8):999-1003. PubMed ID: 27599415
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Dasatinib-induced Pulmonary Hypertension and Drug Dose.
Kubota K; Imai Y; Oh I; Ueno S; Kanda Y; Kario K
Intern Med; 2022 Aug; 61(15):2263-2271. PubMed ID: 35022343
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study.
Weatherald J; Chaumais MC; Savale L; Jaïs X; Seferian A; Canuet M; Bouvaist H; Magro P; Bergeron A; Guignabert C; Sitbon O; Simonneau G; Humbert M; Montani D
Eur Respir J; 2017 Jul; 50(1):. PubMed ID: 28751413
[TBL] [Abstract][Full Text] [Related]
15. Reversible dasatinib-related pulmonary arterial hypertension diagnosed by noninvasive echocardiography.
Wang HC; Lee CS; Liu TC
Kaohsiung J Med Sci; 2015 Mar; 31(3):165-6. PubMed ID: 25744241
[No Abstract] [Full Text] [Related]
16. Pulmonary arterial hypertension in a patient treated with dasatinib: a case report.
Skride A; Sablinskis M; Sablinskis K; Lesina K; Lejnieks A; Lejniece S
J Med Case Rep; 2017 Dec; 11(1):362. PubMed ID: 29287600
[TBL] [Abstract][Full Text] [Related]
17. [Reversible pulmonary arterial hypertension related to dasatinib in the treatment for chronic myelogenous leukemia: a case report and literature review].
Liu B; Wang Y; Mi Y; Wang J
Zhonghua Xue Ye Xue Za Zhi; 2014 Jul; 35(7):581-6. PubMed ID: 25052596
[TBL] [Abstract][Full Text] [Related]
18. [Pulmonary arterial hypertension and chronic heart failure as dasatinib cardiotoxicity. A case report].
Makeeva LM; Emelina EI; Gendlin GE; Nikitin IG; Vasyuk YA; Nesvetov VV
Kardiologiia; 2017 Apr; 57(S4):53-60. PubMed ID: 29466183
[TBL] [Abstract][Full Text] [Related]
19. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
20. Dasatinib-Induced Pulmonary Arterial Hypertension.
Zeb H; El-Kersh K
Am J Ther; 2020 Aug; 28(6):e695-e696. PubMed ID: 32769395
[No Abstract] [Full Text] [Related]
[Next] [New Search]
